Sign In
Buy OTLK
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Outlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 Approval
09:25am, Sunday, 31'st Mar 2024
The positive CHMP opinion could mean possible European Approval; European Commission expected to decide upon approval for this in the next few months. Phase 3 NORSE EIGHT study underway using ONS-5010
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
07:35am, Friday, 22'nd Mar 2024
ISELIN, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizum
All You Need to Know About Oncobiologics (OTLK) Rating Upgrade to Buy
01:01pm, Thursday, 21'st Mar 2024
Oncobiologics (OTLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
05:10pm, Monday, 18'th Mar 2024
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizum
Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
08:05am, Tuesday, 12'th Mar 2024
ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic for
7 of the Best Speculative Stocks You Can Snag for Less Than $1
03:36pm, Wednesday, 06'th Mar 2024
I'm about to drop a truth bomb about speculative stocks under $1. Back when I was a freshman in college, the on-campus security officer had this to say: “Tijuana?
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
01:37pm, Sunday, 25'th Feb 2024
While targeting the therapeutic side of the healthcare sector can be quite lucrative, nothing matches the excitement of biotech penny stocks. Of course, the excitement goes toward both extremes of the
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
08:05am, Wednesday, 14'th Feb 2024
ISELIN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve regulatory approval for the first ophthalmic formulation of be
Outlook Therapeutics® Doses First Subject in NORSE EIGHT
08:05am, Wednesday, 31'st Jan 2024
ISELIN, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizum
Outlook (OTLK) Surges 31% on Regulatory Update for AMD Study
09:11am, Wednesday, 24'th Jan 2024
Outlook (OTLK) stock rises after aligning with the FDA regarding the protocols of a non-inferiority study of ONS-5010 for AMD. The study is set to become the basis for BLA resubmission by 2024-end.
ISELIN, N.J., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizum
NEW YORK , Jan. 2, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022
Best Penny Stocks To Buy Today? 3 To Watch This Week
12:17pm, Monday, 27'th Nov 2023
Penny stocks, or “stocks under $5,” tend to occupy volatile territory with occasional meteoric runs. While savvy short-term traders eagerly scan for these explosive upside trades, penny stocks rem
Invest In Penny Stocks? Is It Worth It & 4 To Watch Now
02:12pm, Tuesday, 07'th Nov 2023
If you're looking for penny stocks to invest in right now, you've got your work cut out for you. That's because the initial strategy when approaching cheap stocks is to trade them in the short term in
3 Penny Stocks To Buy According To Analysts, Targets Up To 365%
05:09pm, Friday, 03'rd Nov 2023
Penny stocks, defined as stocks trading under $5 per share, present traders and investors with opportunities for explosive returns. However, the penny stock territory also comes loaded with substantia
